KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBT: 2009-2024

Historic EBT for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $316.6 million.

  • Incyte's EBT rose 208.14% to $482.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 479.94%. This contributed to the annual value of $316.6 million for FY2024, which is 62.04% down from last year.
  • According to the latest figures from FY2024, Incyte's EBT is $316.6 million, which was down 62.04% from $834.2 million recorded in FY2023.
  • In the past 5 years, Incyte's EBT ranged from a high of $834.2 million in FY2023 and a low of -$232.2 million during FY2020.
  • Its 3-year average for EBT is $560.0 million, with a median of $529.1 million in 2022.
  • As far as peak fluctuations go, Incyte's EBT slumped by 147.70% in 2020, and later soared by 345.65% in 2021.
  • Incyte's EBT (Yearly) stood at -$232.2 million in 2020, then skyrocketed by 345.65% to $570.4 million in 2021, then declined by 7.24% to $529.1 million in 2022, then skyrocketed by 57.66% to $834.2 million in 2023, then tumbled by 62.04% to $316.6 million in 2024.